David Chen,Christopher L. Franklin,Peter R. Guzzo,Linus S. Lin,Michael M. C. Lo,Ravi P. Nargund,Iyassu K. Sebhat
申请号：
US12311487
公开号：
US08193228B2
申请日:
2007.10.16
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.
